1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Cryptococcosis Market, by Treatment
6.1. Introduction
6.2. Amphotericin B
6.3. Fluconazole
6.4. Flucytosine

7. Cryptococcosis Market, by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Mail Order Pharmacies
7.4. Retail Pharmacies & Drug Stores

8. California Cryptococcosis Market

9. Florida Cryptococcosis Market

10. Illinois Cryptococcosis Market

11. New York Cryptococcosis Market

12. Ohio Cryptococcosis Market

13. Pennsylvania Cryptococcosis Market

14. Texas Cryptococcosis Market

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. Abbott Laboratories
16.2. Alkopharma Inc
16.3. Bausch Health Companies Inc.
16.4. Bristol-Myers Squibb Company
16.5. ECR Pharmaceuticals
16.6. Eisai Co.
16.7. Flynn Pharma
16.8. Glenmark Pharmaceuticals
16.9. Johnson & Johnson Services Inc
16.10. Matinas BioPharma
16.11. Meda Consumer Healthcare Inc.
16.12. Merck and Co. Inc.
16.13. Novartis International AG
16.14. NuCare Pharmaceuticals, Inc.
16.15. Pfizer Inc.
16.16. Purdue Pharma L.P.
16.17. Sanofi Pasteur
16.18. Sigmapharm Laboratories, LLC
16.19. SkyePharma
16.20. Teva Pharmaceutical Industries Ltd.
16.21. Viamet Pharmaceuticals,Inc

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES CRYPTOCOCCOSIS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES CRYPTOCOCCOSIS MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2027
FIGURE 6. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY AMPHOTERICIN B, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY AMPHOTERICIN B, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY FLUCONAZOLE, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY FLUCONAZOLE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY FLUCYTOSINE, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY FLUCYTOSINE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2027 (%)
FIGURE 13. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 15. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY MAIL ORDER PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY MAIL ORDER PHARMACIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES CRYPTOCOCCOSIS MARKET: FPNV POSITIONING MATRIX
FIGURE 22. UNITED STATES CRYPTOCOCCOSIS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 23. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES CRYPTOCOCCOSIS MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES CRYPTOCOCCOSIS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY AMPHOTERICIN B, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY FLUCONAZOLE, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY FLUCYTOSINE, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY MAIL ORDER PHARMACIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES CRYPTOCOCCOSIS MARKET: SCORES
TABLE 12. UNITED STATES CRYPTOCOCCOSIS MARKET: BUSINESS STRATEGY
TABLE 13. UNITED STATES CRYPTOCOCCOSIS MARKET: PRODUCT SATISFACTION
TABLE 14. UNITED STATES CRYPTOCOCCOSIS MARKET: RANKING
TABLE 15. UNITED STATES CRYPTOCOCCOSIS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 16. UNITED STATES CRYPTOCOCCOSIS MARKET: MERGER & ACQUISITION
TABLE 17. UNITED STATES CRYPTOCOCCOSIS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 18. UNITED STATES CRYPTOCOCCOSIS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 19. UNITED STATES CRYPTOCOCCOSIS MARKET: INVESTMENT & FUNDING
TABLE 20. UNITED STATES CRYPTOCOCCOSIS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 21. UNITED STATES CRYPTOCOCCOSIS MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Alkopharma Inc
Bausch Health Companies Inc.
Bristol-Myers Squibb Company
ECR Pharmaceuticals
Eisai Co.
Flynn Pharma
Glenmark Pharmaceuticals
Johnson & Johnson Services Inc
Matinas BioPharma
Meda Consumer Healthcare Inc.
Merck and Co. Inc.
Novartis International AG
NuCare Pharmaceuticals, Inc.
Pfizer Inc.
Purdue Pharma L.P.
Sanofi Pasteur
Sigmapharm Laboratories, LLC
SkyePharma
Teva Pharmaceutical Industries Ltd.
Viamet Pharmaceuticals,Inc